Product Pipeline

Acrux has a diversified product portfolio based on high value products, sustainable market advantages, and clear benefits to patients, physicians and healthcare payers.

Formulation Design
Pre-clinical Development
Phase I
Phase II
Phase III
Registration
Commercial
Formulation Design
Pre-clinical Development
Phase I
Phase II
Phase III
Registration
Commercial
Marketed / Specialty Products
Indication(s)
Product name
Phase: Commercial
Eli Lilly
Menopausal symptoms
Estradiol MDTS®* (Europe) - Lenzetto®
Phase: Commercial
Gedeon Richter
Antifungal (Onychomycosis)
ACR-065
Phase: Pre-clinical Development
Product Pipeline




Formulation Development
Process Development
Bioequivalence
Registration
Commercial
Formulation Development
Process Development
Bioequivalence
Registration
Commercial
Generic Products
Product name
ACR-068
Phase: Process Development
ACR-071
Phase: Process Development
ACR-072
Phase: Process Development
Undisclosed
Phase: Formulation Development
Product Pipeline